Brevilin A, a novel LRRC15 inhibitor, exerts potent anti-rheumatoid arthritis effects by inhibiting the LRRC15/STAT3 signaling pathway. Qiao Z, Meng Q, Xiao B, Long Y, et al. Arthritis Res Ther 2025;27:167.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Qiao Z, Meng Q, Xiao B, Long Y, et al. Brevilin A, a novel LRRC15 inhibitor, exerts potent anti-rheumatoid arthritis effects by inhibiting the LRRC15/STAT3 signaling pathway. Arthritis Res Ther 2025;27:167.
PMID: 40835949